Single Cell Analysis Market Thumbnail Image

2022

Single Cell Analysis Market

Single Cell Analysis Market Size, Share, Competitive Landscape and Trend Analysis Report by Product, By Techniques, By End User, By Application : Global Opportunity Analysis and Industry Forecast, 2022-2031

LS : Diagnostics and Biotech

Select an option
Author's: Monika Darandale | Roshan Deshmukh
Publish Date:

Get Sample to Email

Single Cell Analysis Market Statistics, 2031

The global single cell analysis market size was valued at $2.64 billion in 2021, and is projected to reach $13.62 billion by 2031, growing at a CAGR of 17.8% from 2022 to 2031. Increase in demand for single cell analysis is anticipated to increase globally during the forecast period, owing to technological advancement in single cell analysis coupled with increase in R&D in pharmaceutical and biotechnology industry whci also boost single cell analysis market growth.

Single Cell Analysis Market

Single-cell analysis (SCA) is of critical importance in revealing population heterogeneity, identifying minority sub-populations of interest, as well as discovering unique characteristics of individual cells. Microfluidic platforms of single cell analysis work at the scale comparable to cell diameter and are suitable for single-cell manipulation. A microfluidic trapping array which is able to rapidly and deterministically trap single-cells in highly-packed microwells. As the single-cell trapping efficiency is determined by the channel design instead of the flow rate, this trapping array can be coupled with different microfluidic sample processing units with different flow rates for various single-cell analyses. In addition, SCA is widely applied to immunology, microbiology, neurobiology, prenatal diagnosis, embryogenesis, and plant biology.

Growth in stem cell research, rise in focus on personalized medicines and surge in prevalence of cancer further drive the growth of market. However, high cost of single cell analysis products is anticipated to hamper the market growth. Conversely, high growth potential of single cell sequencing is expected to offer lucrative growth opportunities for the key player in the market during single cell analysis market forecast. 

Impact of COVID-19 on Single Cell Analysis Market

Coronavirus (COVID-19) was discovered in December 2019, in Hubei province of Wuhan city in China. A virus, severe acute respiratory syndrome coronavirus 2, causes the disease (SARS-CoV-2), which transmitted among humans. The disease rapidly spread to other parts of the globe post its discovery in Wuhan. Moreover, this virus causes various symptoms in patients, which range from common symptoms to serious symptoms. For instance, common symptoms include fever, dry cough, and fatigue. However, serious symptoms include difficulty in breathing or shortness of breath, chest pain, and loss of speech or movement. Furthermore, the virus has high potential of lethality in geriatric population.

On March 11, 2020, the World Health Organization declared it as a pandemic. In addition, there are only a few vaccines that received emergency approvals for COVID-19 prevention. Thus, social distancing is observed as the most important measure to limit the spread of this disease. Furthermore, to maintain social distancing in various countries across the globe have led to adoption of lockdowns. The COVID-19 outbreak had a positive impact on the single cell analysis industry. Governments all over the world have increased financing for vaccine development and manufacturing as a result of the pandemic's economic and social costs, which has led to an increase in the usage of single-cell analytic tools for COVID-19 research. Although the government imposed a number of restrictions that had an impact on overall production and sales, the demand for single-cell analysis products surged.

A deeper comprehension of the host immune response during illness progression is essential in order to more accurately construct prognostic and diagnostic indicators and establish suitable therapeutic approaches for patients with severe disease presentation. Researchers can gain a better understanding of immune cells at the single-cell level and how functional cells contribute to immune protection by using the single-cell analysis, how the development of more efficient vaccines and immunotherapies is made possible by understanding how functioning cells contribute to immune protection and disease.

Therefore, the market is anticipated to have significant possibilities for growth during the pandemic and provide single cell analysis market opportunity, owing to increase in product demand and continuous research activities (by examining the application of the single-cell analysis approach in the SARS-CoV2).

Single Cell Analysis Market Segmentation 

The single cell analysis market is segmented on the basis of product, application, end user and region. On the basis of product, the market is classified into consumables and instruments. On the basis of application, it is segmented into oncology, immunology, neurology, stem cell, non-invasive prenatal diagnosis, in-vitro fertilization, others. According to technique, the market is categorized into flow cytometry, next generation sequencing, polymerase chain reaction, mass spectrometry and others. On the basis of end user, it is categorized into academic & research laboratories, biotechnology & pharmaceutical companies, hospitals & diagnostic laboratories, cell banks & IVF centers. Furthermore, on the basis of region, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Segments Review

By product, the single cell analysis market is divided into consumables and instruments. The consumables segment has largest market share as well as highest CAGR, and is anticipated to continue this trend during the forecast period, owing to high usability of products and frequent purchase of reagents, increase in prevalence of target diseases and constant need for consumables required for assay.

 

Single Cell Analysis Market
By Product
Your browser does not support the canvas element.

Consumables segment is projected as the most lucrative segment.


By application, the market is divided into oncology, immunology, neurology, stem cell, non-invasive prenatal diagnosis, in-vitro fertilization, others. The oncology segment was the major revenue contributor in 2021, and is anticipated to continue this trend during the forecast period, owing to increase in prevalence of cancer. In addition, single cell analysis proved to be effective for prior diagnostics of cancer cells, thus driving the segment growth.

Single Cell Analysis Market
By Application
Your browser does not support the canvas element.

Neurology segment is projected to be the dominating segment throughout the forecast period.


By technique the market is divided into flow cytometry, next generation sequencing, polymerase chain reaction, mass spectrometry and others. The next generation sequencing segment was the major revenue contributor in 2021, and is anticipated to continue this trend during the forecast period, owing to increase in genome mapping programs, rise in applications of next generation sequencing, increase in healthcare expenditure and technological advancements in sequencing platforms, thus driving the segment growth.

Single Cell Analysis Market
By Techniques
Your browser does not support the canvas element.

Next Generation Sequencing (NGS) segment Enterprises segment was the highest revenue contributor during the forecast period.


By end user, the market is divided into academic & research laboratories, biotechnology & pharmaceutical companies, hospitals & diagnostic laboratories, cell banks & IVF centers.  The biotechnology & pharmaceutical companies segment was the major single cell analysis market share 2021, and is anticipated to continue this trend during the forecast period, owing to technological advancement such as the use of microfluidics for the development of next generation therapies have increased the adoption of single cell analysis by biotechnology and pharmaceutical companies.

Single Cell Analysis Market
By End User
Your browser does not support the canvas element.

Academic and Research Laboratories segment would exhibit a CAGR of 15% during forecast period.


By region, the single cell analysis market is analyzed across North America, Asia-Pacific, Europe, and LAMEA. North America dominated the single cell analysis market size in 2021, accounting for the highest share, and is anticipated to maintain this trend during the forecast period. This is attributed to the rise in well-established healthcare system, increase in number of geriatric patients and supportive reimbursement policies in healthcare system propel the market growth.

Single Cell Analysis Market
By Region
2031
North America 
Europe
Asia-Pacific
LAMEA

North America garnered the largest revenue share in 2021. However, Europe is anticipated to grow at the highest CAGR 21.6% during the forecast period.

The major companies profiled in the report include Becton, Dickinson and Company, Danaher Corporation, Merck KGAA, QIAGEN N.V., Thermo Fisher Scientific, Inc., 10x Genomics, Illumina, Inc., Bio-Rad Laboratories, Agilent Technologies, Inc., Sartorius AG, Takara Holdingsinc, Oxford Nanopore Technologies., Berkley Light INC., BGI Genomics Co.Ltd., Diasorin Group, Dolomite Bio, Standard Biotools.

Key Benefits for Stakeholders

  • This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the single cell analysis market analysis from 2021 to 2031 to identify the prevailing market opportunities.
  • The market research is offered along with information related to key drivers, restraints, and opportunities.
  • Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
  • In-depth analysis of the single cell analysis market segmentation assists to determine the prevailing market opportunities.
  • Major countries in each region are mapped according to their revenue contribution to the global market.
  • Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
  • The report includes the analysis of the regional as well as global single cell analysis market trends, key players, market segments, application areas, and market growth strategies.

Single Cell Analysis Market Report Highlights

Aspects Details
icon_1
Market Size By 2031

USD 13.6 billion

icon_2
Growth Rate

CAGR of 17.8%

icon_3
Forecast period

2021 - 2031

icon_4
Report Pages

270

icon_5
By Product
  • Consumables
  • Instruments
icon_6
By Techniques
  • Flow Cytometry
  • Next Generation Sequencing (NGS)
  • Polymerase Chain Reaction (PCR)
  • Mass Spectrometry
  • Others
icon_7
By End User
  • Academic and Research Laboratories
  • Biotechnology and Pharmaceutical Companies
  • Others
  • Hospitals and Diagnostic Laboratories
icon_8
By Application
  • Oncology
  • Immunology
  • Neurology
  • Stem cell
  • Non-Invasive Prenatal Diagnosis
  • In-Vitro Fertilization (IVF)
  • Others
icon_9
Key Market Players

BGI GENOMICS CO. LTD, Danaher Corporation, 10x Genomics, STANDARD BIOTOOLS (Fluidigm Corporation), Sartorius AG, DOLOMITE BIO, Thermo Fisher Scientific, Inc., BERKLEY LIGHTS INC, OXFORD NANAOPORE TECHNOLOGIES, TAKARA HOLDINGS INC, DIASORIN GROUP (LUMINEX CORPORATION), Merck KGaA, Becton, Dickinson and Company, Bio-Rad Laboratories, Illumina, Inc., Agilent Technologies, Inc., QIAGEN N.V

Analyst Review

Large number of research projects are undertaken to prove the therapeutic and diagnostic potential of single cell analysis, which in turn is expected to stimulate the demand for single cell analysis techniques. In addition, the increase in prevalence of cancer, initiatives taken by government for large scale sequencing projects and increase in cell-based research are further expected to boost the market growth. The single cell analysis market has piqued the interest of healthcare professionals and researchers, owing to their therapeutic and diagnostic potential.
Furthermore, increase in funding by various government and private organizations is expected to drive the single cell analysis market. However, high cost of single cell products is expected to hamper the market growth. The single cell research is the highest in North American region, owing to heavy expenditure by the government on research and experiments. It is followed by Europe and Asia-Pacific, respectively.
 

Author Name(s) : Monika Darandale | Roshan Deshmukh
Frequently Asked Questions?

The total market value of Single cell Analysis Market is $2,645.1 million in 2021.

The forecast period for single cell analysis Market is 2022 to 2031

The base year is 2021 in Single cell Analysis Market

Top companies such as Becton, Dickinson and Company, Danaher Corporation, Merck KGAA, QIAGEN N.V., Thermo Fisher Scientific, Inc., 10x Genomics, Illumina, Inc., Bio-Rad Laboratories held a high market position in 2021.

Consumable segment is the most influencing segment owing to high usability of products and frequent purchase of reagents, increase in prevalence of target diseases and constant need for consumables required for assay.

Technological advancement in single cell analysis coupled with increase in R&D in pharmaceutical and biotechnology industry, growth in stem cell research, rise in focus on personalized medicines and surge in prevalence of cancer are some factor which drive growth of the market.

Single-cell analysis (SCA) is of critical importance in revealing population heterogeneity, identifying minority sub-populations of interest, as well as discovering unique characteristics of individual cells.

Loading Table Of Content...

Loading Research Methodology...

Individual sections of the reports are available for purchase.
Would you like to see a breakdown of prices by section?

Single Cell Analysis Market

Global Opportunity Analysis and Industry Forecast, 2022-2031